Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Cancer Cell|January 7, 2004
p21Waf1/Cip1 as a therapeutic target in breast and other cancersRobert H WeissSeminars in Nephrology|April 1, 2018
Metabolomics and Metabolic Reprogramming in Kidney CancerRobert H WeissUrologic Oncology|September 21, 2011
Urine metabolomics for kidney cancer detection and biomarker discoverySheila Ganti, Robert H WeissNature Reviews. Nephrology|October 26, 2011
Metabolomics in the study of kidney diseasesRobert H Weiss, Kyoungmi KimJournal of the American Society of Nephrology : JASN|February 24, 2004
Exogenous attenuation of p21(Waf1/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1Ya-Ping Fan, Robert H WeissKidney Cancer (Clifton, Va.)|October 19, 2018
Translating Metabolic Reprogramming into New Targets for Kidney CancerOmran Abu Aboud, Robert H WeissKidney International|February 17, 2017
GHetting to know ADPKD proliferative signaling, STATChing-Hsien Chen, Robert H WeissOrganogenesis|March 30, 2013
Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targetsHiromi I Wettersten, Robert H WeissNature Reviews. Urology|April 3, 2013
Potential biofluid markers and treatment targets for renal cell carcinomaHiromi I Wettersten, Robert H WeissPageof 10